Sandoz wins Fed Circ reversal of $39m hair growth patent verdict

The court rules that Duke University and Allergan’s patent lacked sufficient written description, in the wake of stricter post-Amgen Section 112 standards.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

‘I need them and they need me’: Regeneron counsel on what makes a strong law firm partnership

13 November 2025 Regeneron’s Adam Gastonguay shares how to raise the profile of your IP team, get the most from outside counsel, and stay ahead of the growing pressure to adopt AI.

Americas

Less is more: patent lawyers flip the script after Amgen

22 October 2025 The Supreme Court’s 2023 Amgen ruling turned patent strategy upside down. Now lawyers are rethinking everything they thought they knew about protecting inventions. Marisa Woutersen reports from LSPN North America–Fall.

Americas

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

6 May 2025 The ‘Wands factors’ are extending patent litigation—allowing functionally defined claims to survive longer than expected, hears Marisa Woutersen in Boston.

More features

Perkins Coie and Ashurst to merge into $2.7bn revenue firm

Sanofi unit defends booster vaccine trademark in Europe

Pillsbury bags first-chair litigator and inventor with ‘business acumen’

Masimo bags $634m win over Apple—with latest watch under scrutiny

Too busy to save time? Why IP teams can’t afford to wait on AI

AZ counsel warns: EU Bolar exemption is ‘painful’ for pharma innovators

Novartis moves to quash SCOTUS review of Entresto case

Pfizer beats Novo Nordisk in $10bn bidding war

Sandoz wins Fed Circ reversal of $39m hair growth patent verdict

More on this story

Editor's picks

Editor's picks

More features